World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
26431
World Ranking
12316
National Ranking
475

Overview

Gert Jan Fleuren is a researcher affiliated with Leiden University Medical Center in the Netherlands. Their primary focus lies within the field of Medicine, with notable contributions in subfields such as Epidemiology and Surgery.

The researcher's work encompasses several main topics, including:

  • Cervical Cancer and HPV Research
  • Hepatitis B Virus Studies
  • Genital Health and Disease

One of the recent publications authored by Gert Jan Fleuren explores the genotypic diversity relevant to human papillomavirus (HPV) vaccination in lower middle-income countries. The study, titled "Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study", was published in 2022 in the journal Clinical and Experimental Vaccine Research.

Frequent coauthors collaborating with this researcher include:

  • Tofan Widya Utami
  • Andrijono Andrijono
  • Andi Darma Putra
  • Junita Indarti
  • Ekaterina S. Jordanova

The main publication venue for Gert Jan Fleuren's work is Clinical and Experimental Vaccine Research, reflecting the focus on vaccine-related epidemiological studies.

Best Publications

  • Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

    Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  • KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

    Vincent T.H.B.M. Smit;Angelina J.M. Boot;Alida M.M. Smits;Gert Jan Fleuren

  • Ep-CAM : a human epithelial antigen is a homophilic cell-cell adhesion molecule

    Sergey V. Litvinov;Markwin P. Velders;Hellen A. M. Bakker;Gert Jan Fleuren

  • High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

    Sytse J. Piersma;Ekaterina S. Jordanova;Mariëtte I.E. van Poelgeest;Kitty M.C. Kwappenberg

  • Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

    Marij J P Welters;Gemma G Kenter;Sytse J Piersma;Annelies P G Vloon

  • Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity

    Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  • Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

    Annemieke de Jong;Mariëtte I. E. van Poelgeest;Jeanette M. van der Hulst;Jan Wouter Drijfhout

  • Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients

    Haak Hr;Hermans J;van de Velde Cj;Lentjes Eg

  • HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

    V M Howell;C J Haven;K Kahnoski;S K Khoo

  • Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell–Cell Interactions Mediated by Classic Cadherins

    Sergey V. Litvinov;Maarten Balzar;Manon J. Winter;Hellen A.M. Bakker

  • Multiple Genetic Alterations Cause Frequent and Heterogeneous Human Histocompatibility Leukocyte Antigen Class I Loss in Cervical Cancer

    Louise A. Koopman;Willem E. Corver;Arno R. van der Slik;Marius J. Giphart

  • Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries.

    A. M. G. Bunt;J. Hermans;V. T. H. B. M. Smit;C. J. H. Van De Velde

  • Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

    Marij J. P. Welters;Gemma G. Kenter;Peggy J. de Vos van Steenwijk;Margriet J. G. Löwik

  • Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.

    Marij J. P. Welters;Annemieke de Jong;Susan J. F. van den Eeden;Jeanette M. van der Hulst

  • Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens

    Sjoerd H. van der Burg;Sytse J. Piersma;Annemieke de Jong;Jeanette M. van der Hulst

  • Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

    Ekaterina S. Jordanova;Arko Gorter;Ouissam Ayachi;Frans Prins

  • Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

    Anand G Menon;Connie M Janssen van Rhijn;Hans Morreau;Hein Putter

  • In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low‐grade serous tumours

    Nathalie L.G. Sieben;Patricia Macropoulos;Guido M. J. M. Roemen;Sandra M. Kolkman-Uljee

  • Vaccination with HPV16 peptides of patients with advanced cervical carcinoma : Clinical evaluation of a phase I-II trial

    W.J. van Driel;M.E. Ressing;G.G. Kenter;R.M.P. Brandt

  • Occasional Memory Cytotoxic T-Cell Responses of Patients with Human Papillomavirus Type 16-positive Cervical Lesions against a Human Leukocyte Antigen-A*0201-restricted E7-encoded Epitope

    Ressing Me;van Driel Wj;Celis E;Sette A

Frequent Co-Authors

Gemma G. Kenter
Gemma G. Kenter Vrije Universiteit Amsterdam
Arko Gorter
Arko Gorter Leiden University Medical Center
Cees J. Cornelisse
Cees J. Cornelisse Leiden University Medical Center
Ekaterina S. Jordanova
Ekaterina S. Jordanova Vrije Universiteit Amsterdam
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Cornelis J. M. Melief
Cornelis J. M. Melief ISA Pharmaceuticals (Netherlands)
Marij J. P. Welters
Marij J. P. Welters Leiden University Medical Center
Rienk Offringa
Rienk Offringa German Cancer Research Center
Cornelis J.H. van de Velde
Cornelis J.H. van de Velde Leiden University Medical Center
Jan A. Bruijn
Jan A. Bruijn Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, there are numerous online pathways to fast-track your healthcare education. Advanced nursing degrees, such as Doctor of Nursing Practice (DNP) programs, are increasingly accessible online. For students seeking efficiency, shortest dnp programs can help you earn your credentials more quickly without compromising on educational quality.

Flexibility is a growing trend in online healthcare education. Some programs stand out for their reduced requirements, like a dnp program without clinical hours, ideal for those aiming to balance professional advancement with a busy schedule.

Entry-level positions, such as licensed practical nurse (LPN), are also within reach through targeted online learning. lpn programs online can get you started quickly in healthcare settings, serving as a foundation for future growth.

Specialized nursing careers—like psychiatric nurse practitioner—are in high demand. For those interested, consider exploring online psych np programs that offer flexible and expedited pathways to advanced practice.

Best Scientists Citing Gert Jan Fleuren

Trending Scientists

Recently Published Articles